Search Legislation

Commission Regulation (EU) No 272/2014Show full title

Commission Regulation (EU) No 272/2014 of 17 March 2014 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening Options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Commission Regulation (EU) No 272/2014

of 17 March 2014

amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products(1), and in particular the fifth paragraph of Article 12 thereof,

Whereas:

(1) In accordance with Article 67(3) of Regulation (EC) No 726/2004 of the European Parliament and of the Council(2), the revenue of the European Medicines Agency (hereinafter ‘the Agency’) consists of a contribution from the Union and fees paid by undertakings to the Agency. Regulation (EC) No 297/95 lays down the categories and levels of such fees.

(2) Those fees should be updated by reference to the inflation rate of 2013. The inflation rate in the Union, as published by the Statistical Office of the European Union (Eurostat), was 1,5 % in 2013.

(3) For the sake of simplicity, the adjusted levels of the fees should be rounded to the nearest EUR 100.

(4) Regulation (EC) No 297/95 should therefore be amended accordingly.

(5) For reasons of legal certainty, this Regulation should not apply to valid applications which are pending on 1 April 2014.

(6) In accordance with Article 12 of Regulation (EC) No 297/95, the update is to be made with effect from 1 April 2014. It is therefore appropriate that this Regulation enters into force as a matter of urgency and applies from that date,

HAS ADOPTED THIS REGULATION:

Article 1U.K.

Regulation (EC) No 297/95 is amended as follows:

(1)

Article 3 is amended as follows:

(a)

paragraph 1 is amended as follows:

(i)

point (a) is amended as follows:

  • in the first subparagraph, ‘EUR 274 400’ is replaced by ‘EUR 278 500’,

  • in the second subparagraph, ‘EUR 27 500’ is replaced by ‘EUR 27 900’,

  • in the third subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(ii)

point (b) is amended as follows:

  • in the first subparagraph, ‘EUR 106 500’ is replaced by ‘EUR 108 100’,

  • in the second subparagraph, ‘EUR 177 300’ is replaced by ‘EUR 180 000’,

  • in the third subparagraph, ‘EUR 10 600’ is replaced by ‘EUR 10 800’,

  • in the fourth subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(iii)

point (c) is amended as follows:

  • in the first subparagraph, ‘EUR 82 400’ is replaced by ‘EUR 83 600’,

  • in the second subparagraph, ‘EUR 20 600 to EUR 61 800’ is replaced by ‘EUR 20 900 to EUR 62 700’,

  • in the third subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(b)

paragraph 2 is amended as follows:

(i)

the first subparagraph of point (a) is amended as follows:

  • ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(ii)

point (b) is amended as follows:

  • in the first subparagraph, ‘EUR 82 400’ is replaced by ‘EUR 83 600’,

  • in the second subparagraph, ‘EUR 20 600 to EUR 61 800’ is replaced by ‘EUR 20 900 to EUR 62 700’.

(c)

in paragraph 3, ‘EUR 13 600’ is replaced by ‘EUR 13 800’.

(d)

in paragraph 4, ‘EUR 20 600’ is replaced by ‘EUR 20 900’.

(e)

in paragraph 5, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(f)

paragraph 6 is amended as follows:

(i)

in the first subparagraph, ‘EUR 98 400’ is replaced by ‘EUR 99 900’,

(ii)

in the second subparagraph, ‘EUR 24 500 to EUR 73 800’ is replaced by ‘EUR 24 900 to EUR 74 900’.

(2)

in Article 4, ‘EUR 68 400’ is replaced by ‘EUR 69 400’.

(3)

article 5 is amended as follows:

(a)

paragraph 1 is amended as follows:

(i)

point (a) is amended as follows:

  • in the first subparagraph, ‘EUR 137 300’ is replaced by ‘EUR 139 400’,

  • in the second subparagraph, ‘EUR 13 600’ is replaced by ‘EUR 13 800’,

  • in the third subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’,

  • the fourth subparagraph is amended as follows:

    • ‘EUR 68 400’ is replaced by ‘EUR 69 400’,

    • ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(ii)

point (b) is amended as follows:

  • in the first subparagraph, ‘EUR 68 400’ is replaced by ‘EUR 69 400’,

  • in the second subparagraph, ‘EUR 116 000’ is replaced by ‘EUR 117 700’,

  • in the third subparagraph, ‘EUR 13 600’ is replaced by ‘EUR 13 800’,

  • in the fourth subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’,

  • the fifth subparagraph is amended as follows:

    • ‘EUR 34 300’ is replaced by ‘EUR 34 800’,

    • ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(iii)

point (c) is amended as follows:

  • in the first subparagraph, ‘EUR 34 300’ is replaced by ‘EUR 34 800’,

  • in the second subparagraph, ‘EUR 8 600 to EUR 25 700’ is replaced by ‘EUR 8 700 to EUR 26 100’,

  • in the third subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(b)

paragraph 2 is amended as follows:

(i)

point (a) is amended as follows:

  • ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(ii)

point (b) is amended as follows:

  • in the first subparagraph, ‘EUR 41 100’ is replaced by ‘EUR 41 700’,

  • in the second subparagraph, ‘EUR 10 300 to EUR 30 900’ is replaced by ‘EUR 10 500 to EUR 31 400’,

  • in the third subparagraph, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(c)

in paragraph 3, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(d)

in paragraph 4, ‘EUR 20 600’ is replaced by ‘EUR 20 900’.

(e)

in paragraph 5, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

(f)

paragraph 6 is amended as follows:

(i)

in the first subparagraph, ‘EUR 32 800’ is replaced by ‘EUR 33 300’;

(ii)

in the second subparagraph, ‘EUR 8 200 to EUR 24 500’ is replaced by ‘EUR 8 300 to EUR 24 900’.

(4)

in Article 6, ‘EUR 41 100’ is replaced by ‘EUR 41 700’.

(5)

Article 7 is amended as follows:

(a)

in the first paragraph, ‘EUR 68 400’ is replaced by ‘EUR 69 400’,

(b)

in the second paragraph, ‘EUR 20 600’ is replaced by ‘EUR 20 900’.

(6)

Article 8 is amended as follows:

(a)

paragraph 1 is amended as follows:

(i)

in the second subparagraph, ‘EUR 82 400’ is replaced by ‘EUR 83 600’,

(ii)

in the third subparagraph, ‘EUR 41 100’ is replaced by ‘EUR 41 700’,

(iii)

in the fourth subparagraph, ‘EUR 20 600 to EUR 61 800’ is replaced by ‘EUR 20 900 to EUR 62 700’,

(iv)

in the fifth subparagraph, ‘EUR 10 300 to EUR 30 900’ is replaced by ‘EUR 10 500 to EUR 31 400’.

(b)

paragraph 2 is amended as follows:

(i)

in the second subparagraph, ‘EUR 274 400’ is replaced by ‘EUR 278 500’,

(ii)

in the third subparagraph, ‘EUR 137 300’ is replaced by ‘EUR 139 400’,

(iii)

in the fifth subparagraph, ‘EUR 3 000 to EUR 236 500’ is replaced by ‘EUR 3 000 to EUR 240 000’,

(iv)

in the sixth subparagraph, ‘EUR 3 000 to EUR 118 400’ is replaced by ‘EUR 3 000 to EUR 120 200’.

(c)

in paragraph 3, ‘EUR 6 900’ is replaced by ‘EUR 7 000’.

Article 2U.K.

This Regulation shall not apply to valid applications pending on 1 April 2014.

Article 3U.K.

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

It shall apply from 1 April 2014.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 17 March 2014.

For the Commission

The President

José Manuel Barroso

(2)

Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources